Find updates on clinical trials, diagnostics and expanded access in our COVID-19 Hub and learn about the Evidence Accelerator that’s leveraging real-world evidence to help speed response to the global pandemic
Expanded Access (EA) may be considered for patients who have exhausted their treatment options and are not eligible for, or able to participate in, a clinical trial.